Fyenacel Calming Shooter Cellandir Hair Loss-shampoo
Salicylic Acid
H.l.c Group Co., Ltd
Human Otc Drug
NDC 81555-201Fyenacel Calming Shooter Cellandir Hair Loss-shampoo also known as Salicylic Acid is a human otc drug labeled by 'H.l.c Group Co., Ltd'. National Drug Code (NDC) number for Fyenacel Calming Shooter Cellandir Hair Loss-shampoo is 81555-201. This drug is available in dosage form of Shampoo. The names of the active, medicinal ingredients in Fyenacel Calming Shooter Cellandir Hair Loss-shampoo drug includes Salicylic Acid - 2 mg/100mL . The currest status of Fyenacel Calming Shooter Cellandir Hair Loss-shampoo drug is Active.
Drug Information:
| Drug NDC: | 81555-201 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Fyenacel Calming Shooter Cellandir Hair Loss-shampoo |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Salicylic Acid |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | H.l.c Group Co., Ltd |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Shampoo |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | SALICYLIC ACID - 2 mg/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 19 Feb, 2021 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 14 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | H.L.C GROUP Co., ltd
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | O414PZ4LPZ
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 81555-201-01 | 400 mL in 1 BOTTLE (81555-201-01) | 19 Feb, 2021 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose anti dandruff
Product Elements:
Fyenacel calming shooter cellandir hair loss-shampoo salicylic acid glycine scutellaria baicalensis root serine glutamic acid green tea leaf glycyrrhiza glabra rosemary chamomile lysine arginine phenylalanine valine methylpropanediol c12-14 pareth-12 guar hydroxypropyltrimonium chloride (1.7 substituents per saccharide) sodium chloride propylene glycol monolaurate betaine niacinamide glyceryl monocaprylate alcohol lauramidopropyl betaine caprylyl glycol ethylhexylglycerin panthenol 1,2-hexanediol reynoutria japonica root aspartic acid leucine alanine tyrosine proline threonine isoleucine cysteine methionine salicylic acid salicylic acid histidine water sodium c14-16 olefin sulfonate glycerin climbazole butylene glycol citric acid monohydrate edetate disodium anhydrous polyquaternium-7 (70/30 acrylamide/dadmac; 1600000 mw) sodium benzoate menthol, unspecified form tea tree oil centella asiatica whole
Indications and Usage:
Directions after fully wetting hair with water, apply an appropriate amount to hair and scalp, fully lather and wash off with lukewarm water
Warnings:
Warnings consult a specialist, etc. if there are any abnormal symptoms or side effects, such as red spots, swelling or itching, due to direct sunlight when using or after using cosmetics cautions for storage and handling wash the eye immediately when it gets into your eye. be careful not to wash it with water after use as it may cause hair loss or bleaching
Do Not Use:
Warnings consult a specialist, etc. if there are any abnormal symptoms or side effects, such as red spots, swelling or itching, due to direct sunlight when using or after using cosmetics cautions for storage and handling wash the eye immediately when it gets into your eye. be careful not to wash it with water after use as it may cause hair loss or bleaching
Dosage and Administration:
Use[s] hair loss symptom relief shampoo cleanses the scalp of the hair and helps the healthy hair by supplying nutrients as the main ingredient
Package Label Principal Display Panel:
Package label 81555-201-01